← Leaderboards
James Lawrence Wynn
Vanderbilt University
$3,920,007
Attributed
$6,149,184
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2013–22$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$6,149,184 · 3
By mechanism
R01$5,274,474 · 2
K08$874,710 · 1
Top collaborators
- Daniel Irimia5 shared
- Lyle L Moldawer5 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Hsiang Yin$4,455,351
- David E Cliffel$5,635,051
- Lisa J McCawley$3,365,459
- Dmitry Markov$1,301,696
- Katarzyna Anna Rejniak$3,592,414
Others in their field
Top investigators on “Neonatal Sepsis”
- Lakshmi Rajagopal · Seattle Children'S Hospital$11,778,523
- David S Perlin · Hackensack University Medical Center$11,429,593
- Joseph Randall Moorman · Lurie Children'S Hospital Of Chicago$11,358,863
- Waldemar A. Carlo · University Of Alabama At Birmingham$9,168,212
- Matthew R Vogt · Univ Of North Carolina Chapel Hill$7,950,648
- Raul Andino · University Of California San Francisco$7,703,660
Research focus
Neonatal SepsisInfectionImmune ResponseSepsisSepticSignal PathwayTranscriptomicsReceptorPremature InfantPreventInvestigationLifeAdultDiagnosisChildCessation Of LifeMorbidity - Disease RateNeonatalNewborn InfantNeonatePregnancyCostMortalityAttenuated
Grant awards (17)
Modifiable Determinants of Mortality in Neonatal Sepsis$381,250
R01 · FY2022 · GM · contact PI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns$635,840
R01 · FY2021 · HD
Modifiable Determinants of Mortality in Neonatal Sepsis$381,250
R01 · FY2021 · GM · contact PI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns$663,468
R01 · FY2020 · HD
Modifiable Determinants of Mortality in Neonatal Sepsis$381,250
R01 · FY2020 · GM · contact PI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns$668,272
R01 · FY2019 · HD
Modifiable Determinants of Mortality in Neonatal Sepsis$381,250
R01 · FY2019 · GM · contact PI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns$674,060
R01 · FY2018 · HD
Modifiable Determinants of Mortality in Neonatal Sepsis$372,750
R01 · FY2018 · GM · contact PI
Modifiable Determinants of Mortality in Neonatal Sepsis$32,959
R01 · FY2018 · GM · contact PI
Microfluidic Assessment of Clinical Outcomes in Preterm Newborns$702,125
R01 · FY2017 · HD
The Role of the Inflammasome in Neonatal Sepsis$174,942
K08 · FY2017 · GM · contact PI
The Role of the Inflammasome in Neonatal Sepsis$174,942
K08 · FY2016 · GM · contact PI
The Role of the Inflammasome in Neonatal Sepsis$161,929
K08 · FY2015 · GM · contact PI
The Role of the Inflammasome in Neonatal Sepsis$13,013
K08 · FY2015 · GM · contact PI
The Role of the Inflammasome in Neonatal Sepsis$174,942
K08 · FY2014 · GM · contact PI
The Role of the Inflammasome in Neonatal Sepsis$174,942
K08 · FY2013 · GM · contact PI